3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
8
Phase EARLY_PHASE1
3
Phase 4
3
Phase 1
1
Status
Recruiting
2
Unknown
1
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Conditions
Polycystic Ovary Syndrome
3
Hyperandrogenism
2
Gliosarcoma
1
Glioblastoma
1
Endometrial Neoplasms
1
Interventions
Metformin
6
Spironolactone
4
ganirelix
3
Progesterone
3
Pioglitazone
2
Ovidrel
2
Methyltestosterone
2
Hydrocortisone
2
Estradiol
2
Cosyntropin
2
Thyrotropin
1
Testosterone
1
Ortho Evra
1
Luteinizing Hormone
1
Leuprolide
1
LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)-
1
Inositol
1
Flutamide
1
Dexamethasone
1
Contraception
1
Body Mass Index
1
Blood Urea Nitrogen
1
Adrenocorticotropic Hormone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Polycystic Ovary Syndrome
×
Progesterone
×
Clear all
NCT00929006
2025-08-05
CRM003
University of Virginia
Phase EARLY_PHASE1
Recruiting
36 enrolled
NCT03068910
2025-08-05
CRM008
University of Virginia
Phase EARLY_PHASE1
Recruiting
32 enrolled
NCT04597099
2023-11-02
CRM010
University of Virginia
Phase EARLY_PHASE1
Unknown
10 enrolled